Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Stevens

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 6, 2003
Modification of the N-terminus of peptidomimetic protein tyrosine phosphatase 1B (PTP1B) inhibitors: identification of analogues with cellular activityScott D Larsen, F Craig Stevens, Thomas J Lindberg, et al.
Acta Oncologica (Stockholm, Sweden)|March 1, 2021
Is proton beam therapy ready for single fraction spine SBRS? - a feasibility study to use spot-scanning proton arc (SPArc) therapy to improve the robustness and dosimetric plan qualityGang Liu, Xiaoqiang Li, An Qin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 23, 2021
Higher biologically effective dose is associated with improved survival in patients with squamous cell carcinoma of the lung treated with stereotactic body radiation therapyJacob S Parzen, Muayad F Almahariq, Thomas J Quinn, et al.
Acta Oncologica (Stockholm, Sweden)|January 12, 2019
Improving dosimetric outcome for hippocampus and cochlea sparing whole brain radiotherapy using spot-scanning proton arc therapyXuanfeng Ding, Jun Zhou, Xiaoqiang Li, et al.
Radiation Oncology (London, England)|October 8, 2020
Feasibility study: spot-scanning proton arc therapy (SPArc) for left-sided whole breast radiotherapySheng Chang, Gang Liu, Lewei Zhao, et al.
Radiation Oncology (London, England)|November 5, 2020
Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative GroupJacob S Parzen, William Hartsell, John Chang, et al.
Medical Physics|February 20, 2021
Quantifying pulmonary perfusion from noncontrast computed tomographyEdward Castillo, Girish Nair, Danielle Turner-Lawrence, et al.
Oncology (Williston Park, N.Y.)|October 23, 2003
Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancerJaffer A Ajani, Josephine Faust, James Yao, et al.
Physics in Medicine and Biology|December 22, 2022
Introduce a rotational robust optimization framework for spot-scanning proton arc (SPArc) therapySheng Chang, Gang Liu, Lewei Zhao, et al.
Journal of Medicinal Chemistry|January 25, 2002
Synthesis and biological activity of a novel class of small molecular weight peptidomimetic competitive inhibitors of protein tyrosine phosphatase 1BScott D Larsen, Tjeerd Barf, Charlotta Liljebris, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry Letters|March 6, 2003
Modification of the N-terminus of peptidomimetic protein tyrosine phosphatase 1B (PTP1B) inhibitors: identification of analogues with cellular activityScott D Larsen, F Craig Stevens, Thomas J Lindberg, et al.
Acta Oncologica (Stockholm, Sweden)|March 1, 2021
Is proton beam therapy ready for single fraction spine SBRS? - a feasibility study to use spot-scanning proton arc (SPArc) therapy to improve the robustness and dosimetric plan qualityGang Liu, Xiaoqiang Li, An Qin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 23, 2021
Higher biologically effective dose is associated with improved survival in patients with squamous cell carcinoma of the lung treated with stereotactic body radiation therapyJacob S Parzen, Muayad F Almahariq, Thomas J Quinn, et al.
Acta Oncologica (Stockholm, Sweden)|January 12, 2019
Improving dosimetric outcome for hippocampus and cochlea sparing whole brain radiotherapy using spot-scanning proton arc therapyXuanfeng Ding, Jun Zhou, Xiaoqiang Li, et al.
Radiation Oncology (London, England)|October 8, 2020
Feasibility study: spot-scanning proton arc therapy (SPArc) for left-sided whole breast radiotherapySheng Chang, Gang Liu, Lewei Zhao, et al.
Radiation Oncology (London, England)|November 5, 2020
Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative GroupJacob S Parzen, William Hartsell, John Chang, et al.
Medical Physics|February 20, 2021
Quantifying pulmonary perfusion from noncontrast computed tomographyEdward Castillo, Girish Nair, Danielle Turner-Lawrence, et al.
Oncology (Williston Park, N.Y.)|October 23, 2003
Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancerJaffer A Ajani, Josephine Faust, James Yao, et al.
Physics in Medicine and Biology|December 22, 2022
Introduce a rotational robust optimization framework for spot-scanning proton arc (SPArc) therapySheng Chang, Gang Liu, Lewei Zhao, et al.
Journal of Medicinal Chemistry|January 25, 2002
Synthesis and biological activity of a novel class of small molecular weight peptidomimetic competitive inhibitors of protein tyrosine phosphatase 1BScott D Larsen, Tjeerd Barf, Charlotta Liljebris, et al.
Pageof 13